| Patent Number |
Title Of Patent |
Date Issued |
| 8252327 |
Oral controlled release dosage form |
August 28, 2012 |
| A dosage form that provides a controlled release solid dosage form for the oral administration of a central nervous system stimulant, preferably methylphenidate hydrochloride. |
| 7771750 |
Controlled release oral dosage form |
August 10, 2010 |
| A once a day bupropion hydrochloride formulation is disclosed. |
| 7022342 |
Controlled release oral dosage form of beta-adrenergic blocking agents |
April 4, 2006 |
| A sustained release beta-adrenergic receptor blocking agent, preferably propranolol, formulation. |
| 6905708 |
Controlled release oral dosage form |
June 14, 2005 |
| A once a day bupropion hydrochloride formulation is disclosed |
| 6866866 |
Controlled release metformin compositions |
March 15, 2005 |
| A composition for treating patients having non-insulin-dependent diabetes mellitus (NIDDM) by administering a controlled release oral solid dosage form containing preferably a biguanide drug such as metformin, on a once-a-day basis. The dosage form provides a mean time to maximum plasma |
| 6790459 |
Methods for treating diabetes via administration of controlled release metformin |
September 14, 2004 |
| A method for treating patients having non-insulin-dependent diabetes mellitus (NIDDM) by administering a controlled release oral solid dosage form containing preferably a biguanide drug such as metformin, on a once-a-day basis. The dosage form provides a mean time to maximum plasma c |
| 6524620 |
Diltiazem controlled release formulation and method of manufacture |
February 25, 2003 |
| A controlled release diltiazem dosage formulation comprising a plurality of active pellets coated with an extended release coating wherein the active pellets contain diltiazem or a pharmaceutically acceptable salt, a pharmaceutically acceptable inert seed and a binder and the extended |
| 6495162 |
Controlled release oral tablet having a unitary core |
December 17, 2002 |
| A controlled release antihyperglycemic tablet that does not contain an expanding polymer and comprising a core containing the antihyperglycemic drug, a semipermeable membrane coating the core and at least one passageway in the membrane. |
| 6284275 |
Controlled release tablet having a unitary core |
September 4, 2001 |
| A controlled release pharmaceutical tablet containing antihyperglycemic drug and a hypoglycemic drug that does not contain an expanding or gelling polymer layer and comprising a core containing the antihyperglycemic drug and the hypoglycemic drug, a semipermeable coating membrane surroun |
| 6270805 |
Two pellet controlled release formulation for water soluble drugs which contains an alkaline met |
August 7, 2001 |
| A once-a-day controlled release formulation of a water soluble drug is described which includes:(a) from 20 to 50% by weight of enteric polymeric membrane coated pellets comprising a polymer membrane coated core which comprises a biologically inert core which is coated with a first layer |
| 6238703 |
Controlled release oral dosage form of ketoprofen |
May 29, 2001 |
| A controlled release analgesic dosage form comprising: a core comprising an analgesic and binding agent; and a coating comprising an enteric polymer, a water insoluble second polymer and a lubricant. |
| 6197347 |
Oral dosage for the controlled release of analgesic |
March 6, 2001 |
| An oral dosage form that provides for the controlled release of an analgesic wherein the dosage form comprises a core containing an analgesic that is coated with a mixture of an enteric polymer, a water insoluble polymer and a lubricant. |
| 6099862 |
Oral dosage form for the controlled release of a biguanide and sulfonylurea |
August 8, 2000 |
| A controlled release pharmaceutical tablet containing antihyperglycemic drug and a hypoglycemic drug that does not contain an expanding or gelling polymer layer and comprising a core containing the antihyperglycemic drug and the hypoglycemic drug, a semipermeable coating membrane surroun |
| 6099859 |
Controlled release oral tablet having a unitary core |
August 8, 2000 |
| A controlled release antihyperglycemic tablet that does not contain an expanding polymer and comprising a core containing the antihyperglycemic drug, a semipermeable membrane coating the core and at least one passageway in the membrane. |
